The Pharmaceutical Market: Morocco

Date: January 31, 2013
Pages: 101
Price:
US$ 1,295.00
License [?]:
Publisher: Espicom Business Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: PA85748C0B6EN
Leaflet:

Download PDF Leaflet

The Pharmaceutical Market: Morocco
OVERVIEW OF THE PHARMACEUTICAL MARKET IN MOROCCO

Morocco's subsidised health insurance scheme,Régime d'Assistance Médicale (RAMED),launched in March 2012,is experiencing early-stage difficulties with its target to increasehealthcare accessibilityto those on low incomes. This is to be expected, given the evidence of bribery and corruption, and the shortage of doctors in the sector.BMIbelievesthe commitment to improvegovernance and implement controls in the sector will be fulfilled in the medium-to-longterm. As such, we maintainthat government healthcare spending will outpace private healthcare spending over the forecast 2011-2016 period.

Headline Expenditure Projections

Pharmaceuticals: MAD10.10bn (US$1.25bn) in 2011 to MAD11.24bn (US$1.30bn) in 2012; +11.3% in local currency terms and +4.5% in US dollar terms. Forecast broadly unchanged from Q 4 12.

Healthcare: MAD41.99bn (US$5.19bn) in 2011 to MAD47.09bn (US$5.46bn) in 2012; +12.2% in local currency terms and +5.4% in US dollar terms. Forecast slightly higher from Q 4 12 , on account of slightly lower historical figures.

Medical devices: MAD2.19bn (US$270mn) in 2011 to MAD2.47bn (US$287mn) in 2012; +13.1% in local currency terms and +6.2% in US dollar terms. Forecast broadly unchanged from Q 4 12 .

Risk/Reward Rating: In Q113, Morocco remains 12th out of the 30 markets included in the MEA region. Its composite score remains unchanged, at 46.8 out of the maximum 100. The country's rewards ratings are less promising than its risks profile, which weighs down its overall score. The market is medium-sized by regional standards and small on a global scale, but its high growth potential offsets relatively low per capita drug consumption, especially in rural areas. In the risks category, Morocco scores above the regional average, indicating a relatively low level of country and pharmaceutical industry-specific risk in a somewhat volatile region.

Competitive Landscape

The Competitive Landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
EXECUTIVE SUMMARY

SWOT ANALYSIS

    Morocco Pharmaceuticals And Healthcare Industry SWOT
    Morocco Political SWOT
    Morocco Economic SWOT
    Morocco Business Environment SWOT

PHARMACEUTICAL RISK/REWARD RATINGS

    Table: Middle East And Africa Pharmaceutical Risk/Reward Ratings, Q113
    Rewards
    Risks

MARKET SUMMARY – MOROCCO

REGULATORY REGIME

    Intellectual Property Regime
    Pricing Regime
    Reimbursement Regime
    Table: National Insurance Fund Spending On Select Conditions, 2006-2009

INDUSTRY DEVELOPMENTS

    Epidemiology
    Communicable Diseases
    Non-Communicable Diseases
    Healthcare Sector
    Healthcare Financing
    Healthcare Sector Developments
    Healthcare Reform
    Health Insurance
    Recent Health Insurance Developments
    Clinical Trials
    Research & Development
    Medical Devices Market

INDUSTRY FORECAST SCENARIO

    Pharmaceutical Market Forecasts
    Table: Pharmaceutical Sales Indicators 2008-2016
    Healthcare Market Forecast
    Table: Healthcare Expenditure Indicators 2008-2016
    Table: Healthcare Governmental Indicators 2008-2016
    Table: Healthcare Private Indicators 2008-2016
    Key Growth Factors – Macroeconomic Forecast
    Table: Morocco – Economic Activity
    Prescription Drug Market Forecast
    Table: Leading Therapeutic Classes, 2010
    Table: Private Pharmacy Sales Value And Volume By Principal Therapeutic Categories, 2010
    Table: Prescription Drug Sales Indicators, 2008-2016
    Patented Drug Market Forecast
    Table: Patented Drug Market Indicators, 2008-2016
    Morocco Pharmaceuticals & Healthcare Report Q1 2013
    Generic Drug Market Forecast
    Table: Generic Drug Sales Indicators, 2008-2016
    OTC Medicine Market Forecast
    Table: OTC Medicine Sales Indicators, 2008-2016
    Pharmaceuticals Trade Forecast
    Table: Exports And Imports Indicators, 2008-2016
    Medical Device Market Forecast
    Table: Medical Devices Sales Indicators, 2008-2016
    Other Healthcare Data Forecasts
    Key Risks To BMI’s Forecasts

COMPETITIVE LANDSCAPE

    Pharmaceutical Industry
    Table: Members Of AMIP, 2011
    Table: Members Of MIS, 2011
    Domestic Pharmaceutical Sector
    Foreign Pharmaceutical Companies
    Pharmaceutical Wholesale
    Pharmaceutical Retail

COMPANY PROFILES

    Local Companies
    Sothema
    Laprophan
    Promopharm
    Multinational Companies
    Sanofi
    Pfizer
    GlaxoSmithKline
    Ranbaxy
    Table: Morocco's Population By Age Group, 1990-2020 ('000)
    Table: Morocco's Population By Age Group, 1990-2020 (% of total)
    Table: Morocco's Key Population Ratios, 1990-2020
    Table: Morocco's Rural And Urban Population, 1990-2020

GLOSSARY

BMI METHODOLOGY

    How We Generate Our Pharmaceutical Industry Forecasts
    Pharmaceuticals Risk/Reward Ratings Methodology
    Ratings Overview
    Table: Pharmaceutical Business Environment Indicators
    Weighting
    Table: Weighting Of Components
    Sources
Skip to top


The Pharmaceutical Market: Italy US$ 1,295.00 Jan, 2013 · 76 pages
The Pharmaceutical Market: Japan US$ 1,295.00 Jan, 2013 · 99 pages
The Pharmaceutical Market: Jordan US$ 1,295.00 Jan, 2013 · 112 pages

Ask Your Question

The Pharmaceutical Market: Morocco
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: